Want to see FTH full AI Analyst Report?
Faeth Therapeutics (FTH) Ratios
Faeth Therapeutics Ratios
FTH's free cash flow for Q2 2026 was $-15.67M. For the 2026 fiscal year, FTH's free cash flow was increased by $0.00 and operating cash flow was $-15.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.06 | 7.70 | 11.92 | 11.98 | 30.38 |
| Quick Ratio | 5.06 | 7.70 | 11.92 | 11.98 | 30.38 |
| Cash Ratio | 2.04 | 1.83 | 2.31 | 1.96 | 1.46 |
| Solvency Ratio | -4.86 | -4.24 | -3.21 | -3.13 | -5.38 |
| Operating Cash Flow Ratio | -4.81 | -4.53 | -5.67 | -4.30 | -6.19 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 17.20M | $ 34.95M | $ 57.77M | $ 93.62M | $ 141.83M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.08 | 0.08 | 0.07 | 0.02 |
| Debt-to-Equity Ratio | 0.08 | 0.10 | 0.10 | 0.08 | 0.02 |
| Debt-to-Capital Ratio | 0.08 | 0.09 | 0.09 | 0.07 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.23 | 1.18 | 1.15 | 1.14 | 1.05 |
| Debt Service Coverage Ratio | -653.56 | -327.96 | -231.85 | -212.61 | -52.89 |
| Interest Coverage Ratio | -696.50 | -351.81 | -257.39 | -224.29 | -55.94 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.22 | 0.16 | 0.23 | 0.27 | 0.11 |
| Net Debt to EBITDA | 0.34 | 0.21 | 0.20 | 0.21 | 0.14 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 94.60% | 95.24% | 92.01% | 98.92% | 98.16% |
| Return on Assets (ROA) | -92.07% | -66.48% | -45.85% | -41.05% | -24.01% |
| Return on Equity (ROE) | -113.41% | -78.56% | -52.55% | -46.99% | -25.11% |
| Return on Capital Employed (ROCE) | -119.50% | -79.33% | -53.93% | -44.94% | -25.27% |
| Return on Invested Capital (ROIC) | -110.88% | -74.98% | -52.08% | -44.08% | -25.15% |
| Return on Tangible Assets | -92.07% | -66.48% | -45.85% | -41.05% | -24.01% |
| Earnings Yield | -156.74% | -12.25% | -8.81% | -5.31% | -1.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 2.26 | 0.34 | 0.40 | 0.28 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -161.63 | -1082.85 | -903.01 | -1308.67 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 161.63 | 1082.85 | 903.01 | 1308.67 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -16.22 | -0.98 | -1.15 | -1.27 | -1.09 |
| Free Cash Flow Per Share | -16.24 | -0.99 | -1.15 | -1.28 | -1.17 |
| Dividend Paid and CapEx Coverage Ratio | -1278.31 | -168.97 | -177.91 | -121.58 | -14.94 |
| Capital Expenditure Coverage Ratio | -1278.31 | -168.97 | -177.91 | -121.58 | -14.94 |
| Operating Cash Flow Coverage Ratio | -13.55 | -6.42 | -5.16 | -4.86 | -12.85 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -152.16% | -10.08% | -8.32% | -4.30% | -1.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.64 | -8.17 | -11.34 | -18.83 | -87.36 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.72 | 6.41 | 5.96 | 8.85 | 21.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.66 | -9.92 | -12.01 | -23.25 | -99.56 |
| Price-to-Operating Cash Flow Ratio | -0.66 | -9.98 | -12.08 | -23.44 | -106.23 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 4.98 | 0.50 | -1.00 | -0.89 |
| Enterprise Value Multiple | -0.30 | -8.13 | -11.38 | -19.44 | -90.57 |
| Enterprise Value | 6.29M | 240.00M | 380.05M | 905.20M | 3.21B |
| EV to EBITDA | -0.30 | -8.13 | -11.38 | -19.44 | -90.57 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.31 | -9.67 | -11.80 | -23.01 | -99.42 |
| EV to Operating Cash Flow | -0.31 | -9.73 | -11.87 | -23.19 | -106.07 |
| Tangible Book Value Per Share | 14.75 | 1.53 | 2.32 | 3.37 | 5.29 |
| Shareholders’ Equity Per Share | 14.75 | 1.53 | 2.32 | 3.37 | 5.29 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -16.72 | -1.20 | -1.22 | -1.58 | -1.33 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.92 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.97 | 0.82 | 0.94 | 0.80 | 0.82 |
Currency in USD
